青春期发育时机与2型糖尿病关联的系统综述与荟萃分析
该系统综述与荟萃分析纳入28项观察性研究,评估青春期发育时机(主要为女性月经初潮年龄)与2型糖尿病或糖耐量受损的关联。结果显示,月经初潮较晚与较低风险相关,且该关联在调整肥胖指标后仍存在但减弱;英国白人女性中,早初潮归因的2型糖尿病人群归因风险未调整肥胖时为12.6%,调整后为5.1%。
要点
- 月经初潮每推迟一年,2型糖尿病/糖耐量受损风险降低(未调整肥胖RR=0.91)。
- 早初潮者风险升高(未调整肥胖RR=1.39),调整肥胖后关联减弱但仍显著。
- 英国白人女性早初潮归因的2型糖尿病风险未调整肥胖为12.6%,调整后为5.1%。
核心结论
- 月经初潮较早与较高的2型糖尿病/糖耐量受损风险持续相关,且独立于肥胖。
- 相当比例的英国白人女性2型糖尿病与早初潮相关,随全球青春期提前趋势可能增加。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、Medline和Embase至2019年2月。
- 纳入28项观察性研究,均评估女性月经初潮年龄,合并样本量1,228,306;仅1项研究额外纳入男性。
主要发现
- 未调整肥胖模型中,月经初潮每推迟一年,2型糖尿病/糖耐量受损风险RR=0.91(95%CI 0.89-0.93,p<0.001,11个估计,n=833,529,I2=85.4%)。
- 未调整肥胖模型中,早初潮对比晚初潮风险RR=1.39(95%CI 1.25-1.55,p<0.001,23个估计,n=1,185,444,I2=87.8%)。
- 调整肥胖模型中,月经初潮每推迟一年RR=0.97(95%CI 0.95-0.98,p<0.001,12个估计,n=852,268,I2=51.8%)。
- 调整肥胖模型中,早初潮对比晚初潮RR=1.19(95%CI 1.11-1.28,p<0.001,21个估计,n=890,583,I2=68.1%)。
- 关联在白人女性中强于亚洲女性,且在平均初潮年龄较早的人群中更强。
关键数值与推荐
- 英国白人女性早初潮归因的2型糖尿病人群归因风险:未调整肥胖为12.6%(95%CI 11.0-14.3),调整肥胖后为5.1%(95%CI 3.6-6.7)。
临床怎么用
- 评估女性2型糖尿病风险时可考虑月经初潮过早史,但需结合肥胖等已知危险因素。
- 早初潮女性可能是2型糖尿病预防干预的潜在目标人群,但需进一步研究确认因果机制。
局限性
- 存在残余和未测量的混杂因素。
- 月经初潮年龄为自我报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Emerging studies have investigated the association between puberty timing, particularly age at menarche (AAM), and type 2 diabetes. However, whether this association is independent of adiposity is unclear. We aimed to systematically review published evidence on the association between puberty timing and type 2 diabetes (T2D) or impaired glucose tolerance (IGT), with and without adjustment for adiposity, and to estimate the potential contribution of puberty timing to the burden of T2D in the United Kingdom (UK). METHODS AND FINDINGS: We searched PubMed, Medline, and Embase databases for publications until February 2019 on the timing of any secondary sexual characteristic in boys or girls in relation to T2D/IGT. Inverse-variance-weighted random-effects meta-analysis was used to pool reported estimates, and meta-regression was used to explore sources of heterogeneity. Twenty-eight observational studies were identified. All assessed AAM in women (combined N = 1,228,306); only 1 study additionally included men. In models without adjustment for adult adiposity, T2D/IGT risk was lower per year later AAM (relative risk [RR] = 0.91, 95% CI 0.89-0.93, p < 0.001, 11 estimates, n = 833,529, I2 = 85.4%) and higher for early versus later menarche (RR = 1.39, 95% CI 1.25-1.55, p < 0.001, 23 estimates, n = 1,185,444, I2 = 87.8%). Associations were weaker but still evident in models adjusted for adiposity (AAM: RR = 0.97 per year, 95% CI 0.95-0.98, p < 0.001, 12 estimates, n = 852,268, I2 = 51.8%; early menarche: RR = 1.19, 95% CI 1.11-1.28, p < 0.001, 21 estimates, n = 890,583, I2 = 68.1%). Associations were stronger among white than Asian women, and in populations with earlier average AAM. The estimated population attributable risk of T2D in white UK women due to early menarche unadjusted and adjusted for adiposity was 12.6% (95% CI 11.0-14.3) and 5.1% (95% CI 3.6-6.7), respectively. Findings in this study are limited by residual and unmeasured confounding, and self-reported AAM. CONCLUSIONS: Earlier AAM is consistently associated with higher T2D/IGT risk, independent of adiposity. More importantly, this research has identified that a substantial proportion of T2D in women is related to early menarche, which would be expected to increase in light of global secular trends towards earlier puberty timing. These findings highlight the need to identify the underlying mechanisms linking early menarche to T2D/IGT risk.
引用
- Cheng TS, Day FR, Lakshman R, et al. Association of puberty timing with type 2 diabetes: A systematic review and meta-analysis. PLoS Med. 2020. PMID: 31905226. doi:10.1371/journal.pmed.1003017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。